Free Trial

Puma Biotechnology (PBYI) SEC Filings & 10K Form

Puma Biotechnology logo
$3.14 -0.04 (-1.10%)
As of 03:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Puma Biotechnology SEC Filings

DateFilerForm TypeView
02/27/2025
3:22 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:22 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
11:14 AM
ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:11 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/14/2025
7:34 AM
Camber Capital Management LP (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
02/11/2025
5:55 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:58 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:51 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2025
5:53 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:00 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
01/03/2025
6:28 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:31 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:33 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
6:12 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
7:37 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:30 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:33 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
7:34 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
11:12 AM
ACORN BIOVENTURES, L.P. (Filed by)
Puma Biotechnology (Subject)
Form SCHEDULE 13G/A
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Puma Biotechnology (Subject)
Form SC 13G
11/07/2024
3:40 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Puma Biotechnology (Subject)
Form SC 13G
09/16/2024
8:01 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
8:00 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
8:09 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:27 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:00 AM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:41 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:17 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
6:06 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
6:11 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
5:50 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
5:57 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:35 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:36 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:39 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2024
7:43 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
8:19 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:22 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:10 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
8:15 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
07/02/2024
7:44 PM
AUERBACH ALAN H (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:45 PM
HUNT DOUGLAS M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:47 PM
Ludwig Jeffrey Jerome (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
7:48 PM
NOUGUES MAXIMO F (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:18 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
8:19 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:21 PM
MILLER MICHAEL PATRICK (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:22 PM
Puma Biotechnology (Issuer)
Senderowicz Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:25 PM
Puma Biotechnology (Issuer)
Stuglik Brian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:27 PM
Puma Biotechnology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:16 PM
Cesano Alessandra (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
8:17 PM
Dorval Allison (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:18 PM
Dorval Allison (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:21 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:23 PM
Puma Biotechnology (Issuer)
Senderowicz Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:25 PM
Puma Biotechnology (Issuer)
Stuglik Brian M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:27 PM
Puma Biotechnology (Issuer)
WILSON TROY EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:41 PM
Dorval Allison (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:42 PM
MOYES JAY M (Reporting)
Puma Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:43 PM
Puma Biotechnology (Subject)
Senderowicz Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:44 PM
Puma Biotechnology (Subject)
Stuglik Brian M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
8:46 PM
Puma Biotechnology (Subject)
WILSON TROY EDWARD (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:41 PM
Puma Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
3:18 PM
Puma Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PBYI) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners